Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 40

1.

LIMPRINT: The UK Experience-Subjective Control of Swelling in Patients Attending Specialist Lymphedema Services.

Moffatt CJ, Keeley V, Hughes A, Clark K, Lisle J, Benson M, Gaskin R, Sykorova M, Dring E, Murray S, Mercier G, Quere I, Franks PJ.

Lymphat Res Biol. 2019 Apr;17(2):211-220. doi: 10.1089/lrb.2019.0020.

2.

LIMPRINT in Specialist Lymphedema Services in United Kingdom, France, Italy, and Turkey.

Keeley V, Franks P, Quere I, Mercier G, Michelini S, Cestari M, Borman P, Hughes A, Clark K, Lisle J, Benson M, Noerregaard S, Karlsmark T, Murray S, Moffatt C.

Lymphat Res Biol. 2019 Apr;17(2):141-146. doi: 10.1089/lrb.2019.0021.

3.

LIMPRINT: Estimation of the Prevalence of Lymphoedema/Chronic Oedema in Acute Hospital in In-Patients.

Quéré I, Palmier S, Noerregaard S, Pastor J, Sykorova M, Dring E, Franks PJ, Murray S, Keeley V, Bermark S, Karlsmark T, Kyne N, Colgan MP, Coulombe MM, Mestre S, Mercier G, Moffatt CJ.

Lymphat Res Biol. 2019 Apr;17(2):135-140. doi: 10.1089/lrb.2019.0024.

4.

The Development and Validation of the LIMPRINT Methodology.

Moffatt C, Franks P, Keeley V, Murray S, Mercier G, Quere I.

Lymphat Res Biol. 2019 Apr;17(2):127-134. doi: 10.1089/lrb.2018.0081.

5.

The Concept of Chronic Edema-A Neglected Public Health Issue and an International Response: The LIMPRINT Study.

Moffatt C, Keeley V, Quere I.

Lymphat Res Biol. 2019 Apr;17(2):121-126. doi: 10.1089/lrb.2018.0085.

6.

Cancer-associated secondary lymphoedema.

Rockson SG, Keeley V, Kilbreath S, Szuba A, Towers A.

Nat Rev Dis Primers. 2019 Mar 28;5(1):22. doi: 10.1038/s41572-019-0072-5. Review.

PMID:
30923312
7.

Correction to: The prognosis in palliative care study II (PiPS2): study protocol for a multi-centre, prospective, observational, cohort study.

Kalpakidou AK, Todd C, Keeley V, Griffiths J, Spencer K, Vickerstaff V, Omar RZ, Stone P.

BMC Palliat Care. 2018 Nov 3;17(1):121. doi: 10.1186/s12904-018-0373-6.

8.

Lymphedema Research Prioritization Partnership: A Collaborative Approach to Setting Research Priorities for Lymphedema Management.

Underwood E, Woods M, Riches K, Keeley V, Wallace A, Freeman J.

Lymphat Res Biol. 2019 Jun;17(3):356-361. doi: 10.1089/lrb.2018.0026. Epub 2018 Oct 24.

PMID:
30358472
9.

The Prognosis in Palliative care Study II (PiPS2): study protocol for a multi-centre, prospective, observational, cohort study.

Kalpakidou AK, Todd C, Keeley V, Griffiths J, Spencer K, Vickerstaff V, Omar RZ, Stone P.

BMC Palliat Care. 2018 Aug 13;17(1):101. doi: 10.1186/s12904-018-0352-y. Erratum in: BMC Palliat Care. 2018 Nov 3;17(1):121.

10.

Advances in understanding and management of lymphoedema (cancer, primary).

Keeley V.

Curr Opin Support Palliat Care. 2017 Dec;11(4):355-360. doi: 10.1097/SPC.0000000000000311. Review.

PMID:
28984676
11.

Non-adherence to treatment of chronic wounds: patient versus professional perspectives.

Moffatt C, Murray S, Keeley V, Aubeeluck A.

Int Wound J. 2017 Dec;14(6):1305-1312. doi: 10.1111/iwj.12804. Epub 2017 Aug 30.

PMID:
28857457
12.

Identifying priority areas for research into the diagnosis, treatment and prevention of cellulitis (erysipelas): results of a James Lind Alliance Priority Setting Partnership.

Thomas KS, Brindle R, Chalmers JR, Gamble B, Francis NA, Hardy D, Hooper J, Keeley V, Levell NJ, McPhee M, Metcalf L, Santer M, Tarpey M, Smart P, Wallace A, Wilkes S.

Br J Dermatol. 2017 Aug;177(2):541-543. doi: 10.1111/bjd.15634. Epub 2017 Jun 14. No abstract available.

PMID:
28477399
13.

Future Research Priorities for Morbidity Control of Lymphedema.

Narahari SR, Aggithaya MG, Moffatt C, Ryan TJ, Keeley V, Vijaya B, Rajendran P, Karalam SB, Rajagopala S, Kumar NK, Bose KS, Sushma KV.

Indian J Dermatol. 2017 Jan-Feb;62(1):33-40. doi: 10.4103/0019-5154.198039.

14.

Chronic oedema: a prevalent health care problem for UK health services.

Moffatt CJ, Keeley V, Franks PJ, Rich A, Pinnington LL.

Int Wound J. 2017 Oct;14(5):772-781. doi: 10.1111/iwj.12694. Epub 2016 Dec 4.

PMID:
27917617
15.

Development of Prognosis in Palliative care Study (PiPS) predictor models to improve prognostication in advanced cancer: prospective cohort study.

Gwilliam B, Keeley V, Todd C, Gittins M, Roberts C, Kelly L, Barclay S, Stone PC.

BMJ Support Palliat Care. 2015 Dec;5(4):390-8. doi: 10.1136/bmjspcare-2012-d4020rep.

PMID:
26586684
16.

Comparison of multi-frequency bioimpedance with perometry for the early detection and intervention of lymphoedema after axillary node clearance for breast cancer.

Bundred NJ, Stockton C, Keeley V, Riches K, Ashcroft L, Evans A, Skene A, Purushotham A, Bramley M, Hodgkiss T; Investigators of BEA/PLACE studies.

Breast Cancer Res Treat. 2015 May;151(1):121-9. doi: 10.1007/s10549-015-3357-8. Epub 2015 Apr 8.

PMID:
25850535
17.

The lymphatic phenotype in Turner syndrome: an evaluation of nineteen patients and literature review.

Atton G, Gordon K, Brice G, Keeley V, Riches K, Ostergaard P, Mortimer P, Mansour S.

Eur J Hum Genet. 2015 Dec;23(12):1634-9. doi: 10.1038/ejhg.2015.41. Epub 2015 Mar 25. Review.

18.

Factors affecting recruitment to an observational multicentre palliative care study.

Stone PC, Gwilliam B, Keeley V, Todd C, Kelly LC, Barclay S.

BMJ Support Palliat Care. 2013 Sep;3(3):318-23. doi: 10.1136/bmjspcare-2012-000396. Epub 2013 Jan 7.

19.

Antibody persistence and immunologic memory after sequential pneumococcal conjugate and polysaccharide vaccination in HIV-infected children on highly active antiretroviral therapy.

Abzug MJ, Song LY, Levin MJ, Nachman SA, Borkowsky W, Pelton SI; International Maternal Pediatric Adolescent AIDS Clinical Trials Group P1024 and P1061s Protocol Teams.

Vaccine. 2013 Oct 1;31(42):4782-90. doi: 10.1016/j.vaccine.2013.08.002. Epub 2013 Aug 14.

20.

Penicillin to prevent recurrent leg cellulitis.

Thomas KS, Crook AM, Nunn AJ, Foster KA, Mason JM, Chalmers JR, Nasr IS, Brindle RJ, English J, Meredith SK, Reynolds NJ, de Berker D, Mortimer PS, Williams HC; U.K. Dermatology Clinical Trials Network's PATCH I Trial Team.

N Engl J Med. 2013 May 2;368(18):1695-703. doi: 10.1056/NEJMoa1206300.

Supplemental Content

Loading ...
Support Center